Clear Harm From Aspirin-Anticoagulation Combo
Few results are more definitive than the decidedly negative AQUATIC trial of aspirin plus anticoagulation vs anticoagulation alone…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Time to Ditch FDA Warning?
Older women using vaginal estrogen tablets do not face an increased risk for recurrent ischemic stroke, a finding…
COVID-19 ages arteries prematurely with women most affected
A major international study finds COVID-19 survivors, especially women, face signs of accelerated vascular aging, yet early evidence…
New AHA/ASA Policy Statement Urges Stroke Rehab Overhaul
A new policy statement from the American Heart Association/American Stroke Association (AHA/ASA) warns that stroke survivors across the…
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you’re often the first healthcare professional that will identify cardiac issues, including…
Anticoagulants in AF Post-ICH: The Dilemma Continues
TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…